Abstract

An aerobic solution prepared from V(IV) and the cyclic dihydroxamic acid putrebactin (pbH2) in 1:1 H2O/CH3OH at pH = 2 turned from blue to orange and gave a signal in the positive ion electrospray ionization mass spectrometry (ESI-MS) at m/zobs 437.0 attributed to the monooxoV(V) species [VVO(pb)]+ ([C16H26N4O7V]+, m/zcalc 437.3). A solution prepared as above gave a signal in the 51V NMR spectrum at δV = −443.3 ppm (VOCl3, δV = 0 ppm) and was electron paramagnetic resonance silent, consistent with the presence of [VVO(pb)]+. The formation of [VVO(pb)]+ was invariant of [V(IV)]:[pbH2] and of pH values over pH = 2–7. In contrast, an aerobic solution prepared from V(IV) and the linear dihydroxamic acid suberodihydroxamic acid (sbhaH4) in 1:1 H2O/CH3OH at pH values of 2, 5, or 7 gave multiple signals in the positive and negative ion ESI-MS, which were assigned to monomeric or dimeric V(V)– or V(IV)–sbhaH4 complexes or mixed-valence V(V)/(IV)–sbhaH4 complexes. The complexity of the V-sbhaH4 system has been attributed to dimerization (2[VVO(sbhaH2)]+ ↔ [(VVO)2(sbhaH2)2]2+), deprotonation ([VVO(sbhaH2)]+ – H+ ↔ [VVO(sbhaH)]0), and oxidation ([VIVO(sbhaH2)]0 –e– ↔ [VVO(sbhaH2)]+) phenomena and could be described as the sum of two pH-dependent vectors, the first comprising the deprotonation of hydroxamate (low pH) to hydroximate (high pH) and the second comprising the oxidation of V(IV) (low pH) to V(V) (high pH). Macrocyclic pbH2 was preorganized to form [VVO(pb)]+, which would provide an entropy-based increase in its thermodynamic stability compared to V(V)–sbhaH4 complexes. The half-wave potentials from solutions of [V(IV)]:[pbH2] (1:1) or [V(IV)]:[sbhaH4] (1:2) at pH = 2 were E1/2 −335 or −352 mV, respectively, which differed from the expected trend (E1/2 [VO(pb)]+/0 < VV/IV–sbhaH4). The complex solution speciation of the V(V)/(IV)–sbhaH4 system prevented the determination of half-wave potentials for single species. The characterization of [VVO(pb)]+ expands the small family of documented V–siderophore complexes relevant to understanding V transport and assimilation in the biosphere.
Short abstract
The monooxoV(V) complex [VVO(pb)]+ was formed from solutions of VOSO4 and the cyclic dihydroxamic acid putrebactin (pbH2) over pH values of 2−7. The solution speciation of VOSO4 and the linear dihydroxamic acid suberodihydroxamic acid (sbhaH4) showed dimerization ([VVO(sbhaH2)]+ ↔ [(VVO)2(sbhaH2)2]2+), deprotonation ([VVO(sbhaH2)]+ − H+ ↔ [VVO(sbhaH)]0), and oxidation ([VIVO(sbhaH2)]0 − e− ↔ [VVO(sbhaH2)]+) phenomena. The characterization of [VVO(pb)]+ expands the small family of V−siderophore complexes described and is relevant in understanding V transport and assimilation in the biosphere.
Introduction
The ability of microbial siderophores to coordinate metal ions, particularly Fe(III), continues to generate interest in the potential applications of these bioligands in the environment and medicine.1−3 Siderophores produced by terrestrial and marine bacteria have evolved to sequester Fe(III) from insoluble Fe(III)-oxy/hydroxides under oxic and pH neutral environments.4−7 The formation of the Fe(III)–siderophore complex is the first step in siderophore-dependent iron uptake and is essential for the viable growth of almost all environmental and pathogenic bacteria.8−12 Siderophores have diverse structures and have been classified according to the metal ion-binding functional group as catechol-, hydroxamic acid- or citric acid-based compounds.(13) Clinical applications of hydroxamic acid-based siderophores include the mesylate salt of desferrioxamine B for the treatment of iron-overload disease in patients undergoing frequent blood transfusions and suberoylanilide hydroxamic acid, which acts as an anticancer agent via the inhibition of Zn(II) containing histone deacetylases.14−18
While siderophores have evolved as high-affinity Fe(III) complexing agents, these ligands have a rich coordination chemistry with other transition-metal ions in the first and second row of the Periodic Table.(19) Siderophores excreted by marine bacteria compete for Fe(III) and other transition-metal ions present in greater abundance in the ocean, such as Mo(VI) and V(V).(20) Nitrogen fixing Azotobacter vinelandii produces a suite of siderophores that bind Fe(III) and V in order to meet its V requirement for the biosynthesis of V-containing nitrogenase.(21) Desferrioxamine B reactivated V(V)-inhibited enzymes by sequestering the V(V) ion at the active site(22) and the V(V)-hydroxamic acid complexes inhibited the β-lactamase of Enterobacter cloacae P99.(23) Complexes between V(IV) or V(V) and hydroxamic acids lowered blood glucose levels in rat adipocytes(24) and streptozotocin-induced diabetic mice(25) and are under increasing scrutiny as antidiabetic agents. Despite the importance of the coordination chemistry of V and siderophores, there have been few complexes characterized. The triscatecholate-based siderophore enterobactin formed an unusual desoxoV(IV) complex that has been characterized by X-ray crystallography,26,27 and complexes between desferrioxamine B and V(V) have been characterized in solution.(28)
The cyclic dihydroxamic acid-based siderophore putrebactin (pbH2, 1, Chart 1) is a 20-membered macrocycle produced by Shewanella putrefaciens.29−31 The cyclic dihydroxamic acid-based class of siderophores features only two other members: alcaligin produced by pathogenic Bordetella pertussis and B. parapertussis and bisucaberin produced by Alteromonas haloplanktis and Aliivibrio salmonicida.32−35 It was shown by the group that first discovered and fully characterized pbH2 that the Fe(III):pbH2 stoichiometry changed from 1:1 at pH = 2 to 2:3 at pH = 6, with the 6 coordination sites of each of the 2 Fe(III) centers in the latter complex fully saturated by 3 tetradentate pb(2−) ligands.(29) This was similar to the 2:3 complex characterized in solution and in the solid state between Fe(III) and alcaligin33,36 or between Fe(III) and the linear dihydroxamic acid rhodotorulic acid.37,38 Due to the low yields produced in culture and the complex nature of the total syntheses of cyclic dihydroxamic acids,39,40 the coordination chemistry of pbH2 has not been studied beyond Fe(III). Since pbH2 has four hydroxamic acid-derived oxygen donor atoms positioned within a constrained macrocycle, we predicted that pbH2 would form stable mononuclear complexes with oxoV(IV) or oxoV(V) centers, with the oxo group in a five-coordinate species positioned above the metal–ligand plane. This posit was supported by the results from studies of the coordination chemistry of V(V) or Cr(V) and abiological hydroxamic acids.41,42 With limited amounts of native pbH2 available from culture, we have characterized species formed in solution between V(V)/(IV) and pbH2 using electronic absorption spectroscopy, electrospray ionization mass spectrometry (ESI-MS), 51V NMR spectroscopy, electron paramagnetic resonance (EPR) spectroscopy and cyclic voltammetry. To gain insight into the differences in speciation between V(V)/(IV) and cyclic or linear dihydroxamic acids, experiments using the linear dihydroxamic acid suberodihydroxamic acid (sbhaH4, 2,Chart 1) were conducted in parallel.
Chart 1. Putrebactin (pbH2, 1) and Suberodihydroxamic Acid (sbhaH4, 2).
Mapping the species formed from solutions of V(V)/(IV) and a difficult-to-access cyclic dihydroxamic acid-based siderophore native to a bacterial species of Shewanella has implications for a better understanding of V(V)/(IV)-siderophore chemistry in marine environments.
Experimental Section
Chemicals and Bacterial Strain
All reagents were obtained from commercial sources and used without further purification. Suberodihydroxamic acid (sbhaH4) and NaVO3 were purchased from Sigma-Aldrich Co. VOSO4·5H2O was obtained from Merck. S. putrefaciens 8071T was obtained from the American Type Culture Collection (ATCC). Methanol and acetonitrile were HPLC grade from LabScan. Milli-Q water (18.2 Ω) was used in all experiments. The pH values of the solutions were adjusted with 0.1 M NH4OH, 0.1 M NaOH, or 0.1 M HCl, as stipulated. As measured for each solution at t = 15 min after preparation and at t = 1 h after analysis, the change in the pH value in all experiments was <0.1 pH unit.
Instrumentation
ESI-MS was carried out using a Finnigan LCQ mass spectrometer (San Jose, CA) in both positive and negative ion modes. The mobile phase was methanol, with a flow rate = 0.20 mL min–1, cone voltage was 25 V, and the injection volume was 20 μL. Electronic absorption spectra were acquired with a Cary 1E UV–vis spectrophotometer. 1H NMR spectra were recorded on a 300 MHz Bruker Avance300 NMR spectrometer at 300 K. 51V NMR spectra were recorded at 105 MHz on a 400 MHz Bruker DPX400 NMR spectrometer using a capillary VOCl3 reference (0 ppm). EPR spectra were acquired using a Bruker Elexsys 500 spectrometer at 150 K under the following conditions: Center field, 3330 G; sweep width, 2000 G; resolution, 1024; modulation frequency, 100 kHz; modulation amplitude, 2 G; time constant, 1.28 ms; conversion time, 40.96 ms; microwave power, 6.241 mW; microwave frequency, 9.3470 GHz; and no. of scans, 20. Cyclic voltammetry experiments were carried out using a Bioanalytical Systems BAS 100B Electrochemical Analyzer (scan rate, 100 mV s–1), 100% iR compensation) with a Pt working electrode, a Ag/AgCl reference electrode, and Pt wire as an auxiliary electrode. Samples were degassed with Ar for 10 min prior to data acquisition.
Purification of pbH2 from S. putrefaciens 8071T
The culture supernatant of two large-scale, Fe(III)-deficient cultures of S. putrefaciens 8071T (30 and 50 L culture medium) were purified as previously described.29,43 The pbH2 obtained from the 30-L culture (26.6 mg) was dissolved in an aliquot (∼7 mL) 1:1 CH3OH/H2O at pH = 2 (∼10.2 mM, Batch 1), and the pbH2 obtained from the 50-L culture (64.4 mg) was dissolved in an aliquot (17.2 mL) of 1:1 CH3OH/H2O at pH = 2 (∼10 mM, Batch 2). Based on RP-HPLC and 1H NMR spectroscopic measurements, Batch 1 was ∼50% pure and Batch 2 was ∼40% pure. Some experiments used a solution of pbH2 (∼11 μM in 40:60 CH3OH/H2O, pH = 2) that had not been purified by RP-HPLC (Batch 3).
Solution Preparation: Electronic Absorption Spectroscopy and ESI-MS
Solid VOSO4·5H2O (0.03 g, 0.12 mmol) was added to an aliquot of pbH2 (2 mL, ∼20 μmol, Batch 1) to give a V(IV):pbH2 solution in a ∼6:1 ratio at pH = 2. The resulting purple/red solution was stirred at room temperature. After standing overnight at room temperature, the solution was subjected to ESI-MS (positive ion mode) and an electronic absorption spectrum was obtained (300–900 nm). The solution was stored in a closed vial at room temperature for 15 months, and the positive ion ESI-MS was reacquired after this time. An aliquot of an aqueous solution of VOSO4·5H2O (200 μL, 1 mM) was added to an aliquot of pbH2 (100 μL, Batch 3), and the solution was monitored by electronic absorption spectroscopy (300–900 nm) every 2 min over 90 min and again at 24 h. An aliquot of an aqueous solution of NaVO3 (30 μL, 1 mM) was added to an aliquot of pbH2 (750 μL of Batch 3) to give a V(V):pbH2 solution in approximately a 3.5:1 ratio, and the pH value was adjusted to pH = 2. After stirring at room temperature overnight, the yellow/orange solution was analyzed by positive and negative ion ESI-MS. An aliquot of an aqueous solution of VOSO4·5H2O (200 μL, 1 mM) was added to an aliquot of pbH2 (100 μL, Batch 3), the pH value of the solution was adjusted to pH = 2, and the solution was analyzed by negative ion ESI-MS. An aliquot of an aqueous solution of VOSO4·5H2O (4 mL, 10 mM) was added to an aliquot of pbH2 (4 mL, Batch 2), and the orange solution was stirred at room temperature. After standing overnight at room temperature, the solution was lyophilized to yield a solid purple residue. The purple solid was dissolved in methanol (1 mL) to give an orange solution, which was applied to a Sephadex LH-20 column (16 × 1.2 cm i.d., CV = 18.1 cm3) which was eluted with CH3OH (flow rate ∼0.5 mL min–1). An orange band eluted at 10 mL, and a yellow band eluted at 25 mL. Both fractions were collected and analyzed by positive and negative ion ESI-MS. Solutions of VOSO4·5H2O (1 mM stock solution in 10 mM HCl) and pbH2 were prepared in which [V(IV)]:[pbH2] = 1:1 (pH = 2); 1:1.5 (pH = 2 or 7); 1:2 (pH = 7) and were analyzed by positive and negative ion ESI-MS and by electronic absorption spectroscopy.
An aliquot of an solution of VOSO4·5H2O in 0.1 M HCl (1 mL, 10 mM) was added to an aliquot of sbhaH4 (2 mL, 10 mM) in 1:1 CH3OH:H2O and the pH value of the solution was adjusted to pH = 2 with 0.1 M HCl. Three additional solutions were prepared at pH = 5, 7, and 9. Each solution was analyzed by positive ion and negative ion ESI-MS and by electronic absorption spectroscopy.
Solution Preparation: 51Vanadium NMR Spectroscopy
An aliquot of an aqueous solution of VOSO4·5H2O (0.4 mL, 10 μM) was added to an aliquot of pbH2 (0.4 mL, 10 μM, Batch 2), and the orange solution (pH = 2) was left to stand overnight at room temperature. The solution was lyophilized to dryness, and the residue was dissolved in methanol (∼1 mL) before passing the solution through a Sephadex LH-20 column, as described above. The orange band was collected, the solution was lyophilized, and the residue was dissolved in CD3OD (0.5 mL) for analysis by 51V NMR spectroscopy. An aliquot of a D2O solution of VOSO4·5H2O (0.167 mL, 2 mM) was added to an aliquot (0.333 mL, 2 mM) of sbhaH4 in D2O, and the pH value of the solution was adjusted to pH = 2 using 0.1 M HCl (5 μL of 10.17 M HCl in 5 mL D2O). Two additional V(IV):sbhaH4 = 1:2 solutions were prepared at pH = 5 or 7, with the pH values of the solutions adjusted using 0.1 M NaOH (20 mg NaOH in 5 mL D2O).
Solution Preparation: EPR Spectroscopy
Methanol stock solutions of: VOSO4·5H2O at 10 mM (0.063 g in 25 mL) or 1 mM (0.0063 g in 25 mL) or sbhaH4 at 10 mM (0.0511 g in 25 mL) were prepared. An aliquot of a methanol solution of VOSO4·5H2O (5 μL, 1 mM) was added to an aliquot of pbH2 (900 μL, ∼11 μM, Batch 3) to give an approximately V:pbH2 = 1:2 solution. The solution was purified by Sephadex LH-20 column chromatography, as described above, and the orange band was subject to EPR analysis at 150 K. An aliquot of a methanol solution of VOSO4·5H2O (1 mL, 10 mM) was added to a methanol solution of sbhaH4 (2 mL, 10 mM), and the pH value of the solution was adjusted with 0.1 M HCl to pH = 2. The solution was left at room temperature for 15 min prior to EPR analysis at 150 K. A second V(IV):sbhaH4 = 1:2 solution was prepared as above, and the pH value was adjusted to pH = 5 with 0.1 M NH4OH.
Solution Preparation: Electrochemistry
An aliquot (1 mL) of an aqueous solution of VOSO4 (10 mM) was added to ∼25 μmol pbH2, and the orange solution was passed through an LH-20 column as described above, and was eluted with methanol. The orange band was collected, and the methanol was removed to yield 10.5 mg of purple solid which was dissolved in 5 mL of 0.1 M NaCl. The pH value of the solution was adjusted to pH = 2. An aliquot (2 mL) of sbhaH4 (10 mM in 0.1 M NaCl) was added to an aliquot (1 mL) of VOSO4 (10 mM in 0.1 M NaCl). The volume was made to 6 mL with 0.1 M NaCl solution to give a final solution of [V(IV)]:[sbhaH2] = 1.67 mM:3.33 mM, and the pH value of the solution was adjusted to pH = 2.
Results and Discussion
Rationale
In this study, the coordination chemistry of V(IV) and cyclic pbH2 or linear sbhaH4 has been explored. Due to the limited yields of pbH2 obtained from iron-limited cultures of S. putrefaciens, the coordination chemistry of pbH2 has not been studied beyond Fe(III).(29) The configuration of the oxygen donor atoms of pbH2 suggested that this ligand would form stable complexes with oxoV(IV) or oxoV(V) which is of interest in the context of siderophores in the marine environment, particularly given that many species of Shewanella are marine bacteria(44) and that in seawater V is present at 20–35 pM and is second to Mo as the most abundant transition metal.20,45 This work has mapped solution species formed between V(IV) and pbH2 or sbhaH4 using electronic absorption spectroscopy, positive and negative ion mode ESI-MS, 51V NMR spectroscopy, EPR spectroscopy, and cyclic voltammetry.
Electronic Absorption Spectroscopy
The solution formed from mixing V(IV) with pbH2 (1:1 CH3OH/H2O at pH = 2) in an approximate 6:1 ratio was initially blue in color. After stirring for 1 h, the solution became dark-purple/red in color and gave an electronic absorption spectrum with λmax at 452 and 760 nm. Hydroxamic acids are known to form highly colored complexes with V, which has been used for the analytical detection of submillimolar amounts of V.46,47 A time-course study with [V(IV)] > [pbH2] showed that the distribution of species formed between V and pbH2 reached equilibrium at t = 90 min, with the spectrum acquired at 24 h similar to that at t = 90 min (Figure 1). There were two isosbestic points at 354 and 630 nm, indicating the presence of at least two species in solution. One of these species was VOSO4, as indicated by the peak at 760 nm. The peak at 452 nm compared well with the electronic absorption spectra of previously characterized V(V)–hydroxamato complexes in CH3OH/H2O solutions(41) and was similar to the spectrum from a red solution prepared from V(IV) and sbhaH4 (λmax = 444 nm, Figure 1 inset, dashed line) in which the V(IV) had been oxidized to V(V). The electronic spectrum from a solution prepared from V(IV) and pbH2, where [pbH2] > [V(IV)] (Figure 1 inset, solid line) was similar to that of the V(V)-sbhaH4 spectrum, which suggested that a solution of V(IV) and pbH2 yielded V(V)-pbH2 species.
Figure 1.
Electronic absorption spectra from an aqueous solution of VOSO4·5H2O (1 mM) and pbH2 (<1 mM) acquired over 2 min intervals for 90 min. The inset shows the electronic absorption spectra from an aqueous 1:2 solution of V(IV) and shbaH4 (pH = 5, dashed line) or an aqueous 1:1 solution of V(IV) and pbH2 (pH = 2, solid line).
ESI-MS from Solutions of V(IV) or V(V) and pbH2
The ESI-MS (positive ion) spectrum from the ∼6:1 V(IV):pbH2 solution at pH = 2 gave a major signal at m/z 437.0 (100%, Figure 2a), which formulated as the V(V) species [VVO(pb)]+ ([C16H26N4O7V]+, m/zcalc 437.3) in which pb(2−) coordinates in a tetradentate fashion to a monooxoV(V) center to give a five-coordinate species (Scheme 1, 3). A model of [VVO(pb)]+ built using HyperChem 7.5 from X-ray crystal structure data of Fe2(alcaligin)3(36) and bis(thiomaltolato)oxoV(IV)(48) shows pb(2−) forming a bucket-type structure below the V(V) ion, which, similar to Fe(III)-alcaligin, lifts the metal ion out of the plane (Figure 3). This structure would be expected to prevent other ligands coordinating trans to the oxo group.(41) An additional methanol, hydroxyl or water ligand would give a six-coordinate complex, such as [VVO(OH)(pb)], with the ancillary ligand cis to the oxo group.
Figure 2.
Positive ion ESI-MS spectra from 1:1 H2O:CH3OH solutions at pH = 2 of: (a) V(IV):pbH2 ∼6:1; (b) V(V):pbH2 = ∼3.5:1; (c) V(IV):pbH2 ∼1:1 after purification by Sephadex LH-20; and (d) V(IV):pbH2 ∼6:1 after 15 months aging. Negative ion ESI-MS spectra from 1:1 H2O:CH3OH solutions at pH = 2 of: (e) V(IV):pbH2 ∼1:1 and (f) V(V):pbH2 ∼1:1.
Scheme 1. Structures of [VVO(pb)]+ (3), [(VVO)2(pb)2]2+ (4), and [VVO(OH)(pb)] (5).
Figure 3.

Predicted structure of [VVO(pb)]+ based upon the X-ray crystal structure of Fe2(alcaligin)3.(36) H atoms have been omitted for clarity.
The ESI-MS signal simulated well as [VVO(pb)]+ (Figure 2a, inset). This species may be in equilibrium with the dimeric species [(VVO)2(pb)2]2+ ([C32H52N8O14V2]2+, m/zcalc 437.3) where two oxo groups bridge the two V(V) centers to form a hexacoordinate bis(μ-oxo) complex (4, Scheme 1). Compressed ESI-MS isotope patterns can be used to differentiate between mononuclear and dimeric coordination complexes with hydroxamic acid in cases where the metal ion, such as Fe(III) or Ga(III), is polyisotopic.(49) Since V is monoisotopic (natural abundance 51V, 99.75%), the nuclearity of complexes will not be reflected in compressed ESI-MS isotope patterns. Therefore, signals due to [VVO(pb)]+ and [(VVO)2(pb)2]2+ would be indistinguishable at the level of ESI-MS. Signals in the ESI-MS at m/zobs 468.1 (7%) and 491.0 (21%) were attributed to [VVO(pb)(CH3OH)]+ (m/zcalc 469.4) and the Na+ adduct of [VVO(pb)(OCH3)] (m/zcalc 491.4), respectively. Signals corresponding to pbH2 ([M + H]+m/zcalc 373.2) or its adducts were not observed. The presence of the intrinsically uncharged V(IV) complex [VIVO(pb)] is discounted since the [M + H+]+ adduct of this species would be expected to give a signal in the positive ion ESI-MS centered at m/zobs 438.4, which was not the case. The orange/red color of the solution, the electronic absorption spectrum and the ESI-MS data supported the formation of [VVO(pb)]+ from solutions of V(IV) and pbH2. Previous work has established the formation of V(V)–hydroxamic acid complexes from V(IV) and described the orange color of methanol solutions of these complexes and the violet color of methanol free residues.41,47,50 This was similar to the physical characteristics of the [VVO(pb)]+ system. If [VVO(pb)]+ was being formed from a solution of V(IV) and pbH2, then the ESI-MS from this solution would be expected to be similar to that from a solution of V(V) and pbH2, where no redox chemistry was taking place. A dilute solution of NaVO3 and pbH2 gave a signal in the ESI-MS (positive ion) at m/zobs 437.1 (Figure 2b) with other signals at m/z values similar to those observed for the solution prepared from V(IV) and pbH2. The relative concentration of the signal at m/zobs 437.0 in the ESI-MS ascribed to [VVO(pb)]+ was largely invariant of pH value and of the [V(IV)]:[pbH2] ratio (Table 1). This contrasts with the Fe(III)-pbH2 or -alcaligin systems, which show a pH-dependent distribution of complexes of different stoichiometries.29,33,36,38
Table 1. Positive and negative ion mode ESI-MS data from 1:2 solutions of V(IV) and pbH2 or sbhaH4 at pH = 2, 5 or 7.
| pH |
|||||
|---|---|---|---|---|---|
| 2 | 5 | 7a | |||
| species | no. | m/zcalcb | m/zobs (%) | m/zobs (%) | m/zobs (%) |
| [VVO(pb)]+c | 3, 4 | 437.3 | 436.9 (100) | NCd | 437.1 (100) |
| [VVO(OH)(pb)]e | 5 | 455.3 | 454.7 (100)f | ||
| [sbhaH4]e | 2 | 205.2 | NDg | ND | 204.7 (38) |
| [sbhaH3]− | 2 | 203.2 | ND | ND | 203 (29) |
| [sbhaH3·sbhaH4]− | 2 | 407.4 | ND | ND | 407 (10) |
| [VVO(sbhaH2)]+, [(VVO)2(sbhaH2)2]2+ | 6, 12 | 269.1 | 268.7 (7) | 268.7 (4) | 268.8 (3) |
| [VVO(sbhaH2)(CH3OH)]+, [(VVO)2(sbhaH2)2(CH3OH)2]2+ | 6·M, 12·M | 301.1 | 300.4 (100) | 300.5 (100) | 300.5 (100) |
| [VVO(sbha)]−, [(VVO)2(sbha)2]2– | 10, 24 | 267.1 | 266.6 (3) | 266.9 (6) | 267 (47) |
| [VVO(sbha)(CH3OH)]−, [(VVO)2(sbha)2(CH3OH)2]2– | 10·M, 24·M | 299.2 | ND | ND | 300.8 (20) |
| [(VIVO)(VVO)(sbhaH2)2]+ | 14 | 538.2 | 537.5 (6) | 537.8 (5) | 537.9 (5) |
| [(VVO)2(sbhaH2)(sbhaH)]+ | 15 | 537.3 | ND | 536.9 (6) | 536.9 (12) |
| [(VVO)2(sbhaH2)(sbhaH)(CH3OH)]+ | 15·M | 569.3 | ND | 568.8 (12) | 568.8 (20) |
| [(VIVO)2(sbhaH2)(sbhaH)(CH3OH)]− | 16·M | 569.3 | 569.8 (47) | ND | ND |
| [VIVO(sbhaH)(CH3OH)]−, [(VIVO)2(sbhaH)2(CH3OH)2]2– | 9·M, 19·M | 300.1 | 300.6 (90) | ND | ND |
| [(VIVO)(VVO)(sbhaH)2(CH3OH)]− | 20·M | 569.3 | 568.7 (42) | ND | ND |
| [(VVO)2(sbhaH)(sbha)]− | 21 | 535.3 | ND | 534.9 (6) | 534.9 (42) |
| [(VVO)2(sbhaH)(sbha)(CH3OH)]− | 21·M | 568.3 | ND | ND | 568.9 (20) |
Spectra acquired at pH = 9 were similar to those at pH = 7.
m/zcalc for M+ or M– ion, unless otherwise specified.
The metal:pbH2 ratio was 1:1.5 at pH = 2.
NC is not acquired.
m/zcalc for [M + H+]+.
Aged solution.
ND is not detected.
One orange and one yellow band were resolved using LH-20 size exclusion chromatography from a methanol solution prepared from V(IV) and pbH2. The orange fraction analyzed in the positive ion ESI-MS as [VVO(pb)]+ (m/zobs 437.3) (Figure 2c). As a result of the methanol-based chromatographic procedure the intensity of the signal ascribed to [VVO(pb)(CH3OH)]+ in this solution (m/zobs 468.7) was similar to the intensity of the signal for [VVO(pb)]+. The complex signals between m/zobs 356.1 to 358.1 could be ascribed to an pbH2 adduct with one hydroxamic acid group reduced to an amine (C16H29N4O5, [M + H+]+m/zcalc 357.4). The positive ion ESI-MS from the yellow fraction contained no free pbH2 and was likely to contain polyoxovanadates.
The solution of V-pbH2 that had been stored at room temperature for 15 months, gave rise to a signal at m/zobs 454.7 (100%) (Figure 2d), which was consistent with the six-coordinate species [VVO(OH)(pb)] ([M + H+]+, m/zcalc 455.3) in which a hydroxide ligand has coordinated to [VVO(pb)]+ (5, Scheme 1). The time period over which [VVO(OH)(pb)] formed was not clear, since ESI-MS spectra were acquired from solutions of V(IV) and pbH2 that were aged for <1 d and 15 months but not in between these times. Attempts to isolate the CF3SO2– salt of [VVO(pb)]+ and to bind [VVO(pb)]+ to a cation-exchange resin from 1 to 2 day-old solutions of V(IV) and pbH2 were unsuccessful, which indicates that the concentration of [VVO(OH)(pb)] may be significant over time periods <15 months.
The presence of six-coordinate [VVO(OH)(pb)] suggested that cis-dioxoV(V)-pbH2 species, such as [VVO2(pb)]−, might be present. None of the signals in the negative ion ESI-MS from a solution of V(IV) and pbH2 were ascribable to cis-dioxoV(V)-pbH2 species (Figure 2e). The signal at m/z 485.1 in the negative ion ESI-MS from a solution of V(V) and pbH2 could be ascribed to the methanol adduct [VVO2(pb)]−·CH3OH (m/zcalc 485.4) (Figure 2f). The relative concentration of this species is low (7%). The remaining signals in the negative ion spectrum are attributed to background ions or impurities in pbH2.
ESI-MS from Solutions of V(IV) and sbhaH4: Opening Comments
Spectra were acquired from 1:2 solutions of V(IV):sbhaH4 at pH = 2, 5, 7 (Figure 4), and 9 and from a 1:1 solution of V(IV):sbhaH4 at pH = 2 (Table S1, Supporting Information). Compared to pbH2, more signals were present in spectra from solutions of V(IV) and sbhaH4, which suggested a more complex speciation profile. This increased complexity was made more acute by the fact that sbhaH4 was pure and that signals were not attributable to ligand impurities. Based on previous work, it was reasonable to expect that dihydroxamate or dihydroximate complexes would predominate at low or high pH values, respectively.51−56 The former complexes would more likely be detected by positive ion mode ESI-MS and the latter complexes by negative ion mode. Mixed hydroxamate/hydroximate complexes might form at intermediate pH values, some of which could be intrinsically uncharged and MS-inactive. Further, since the V(IV) ion is more acid stable than the V(V) ion, it was reasonable to expect that at pH = 2, [V(IV)-sbhaH4] > [V(V)-sbhaH4] and at pH = 7 [V(V)-sbhaH4] > [V(IV)-sbhaH4]. This was borne out from the results of the 51V NMR and EPR spectroscopy experiments (discussed further below).
Figure 4.
Positive ion ESI-MS spectra from 1:2 solutions of V(IV):sbhaH4 in 1:1 H2O:MeOH at: (a) pH = 2, (b) pH = 5, or (c) pH = 7. Negative ion ESI-MS spectra from 1:2 solutions of V(IV):sbhaH4 in 1:1 H2O:MeOH at: (d) pH = 2, (e) pH = 5, or (f) pH = 7. Simulated spectra of selected species are shown in the insets.
In the negative ion ESI-MS data there was a discontinuity in the signals observed from solutions at pH = 5, compared to pH = 2 and 7. The major signal at m/zobs 300.6 present in the spectrum at pH = 2 and m/zobs 300.8 at pH = 7 (Figure 4 panels d and f, respectively) was absent in the spectrum at pH = 5 (Figure 4, panel e). This suggested that MS-active species were present in relatively high concentrations at pH = 2 and 7 and that intrinsically uncharged MS-inactive species were present in relatively high concentrations at pH = 5. Further, this discontinuity indicated that although the m/z values of the major signals were similar, the signal at m/zobs 300.6 at pH = 2 could not be ascribed to the same species that gave the signal at m/zobs 300.8 at pH = 7. The most likely explanation for the observed discontinuity was that the two species giving rise to the signals with similar m/z values varied in the oxidation state of the V center(s) and/or the protonation state of the complex.
A theoretical map of the solution equilibria of V(V)/(IV)–sbhaH4 complexes (Scheme 2) shows several phenomena, including dimerization (eqs 1 and 2, refer to dotted boxes in Scheme 2), deprotonation (eqs 3 and 4), and oxidation (eqs 5 and 6). At any given pH value, these processes would yield a mixture of complexes with different charges (refer to upper horizontal bars of Scheme 2). While ESI-MS data are not an accurate reflection of equilibrium conditions, this map served to aid assigning signals to species and in providing possible pathway(s) for the formation and transformation of species.
Scheme 2. Major Species Present in Solutions Analyzed by ESI-MS Prepared From V(IV) and sbhaH4 As a Function of pH Value.
The m/zcalc for each species is given below the structure and the m/zcalc value of the methanol adduct is given in parentheses.
ESI-MS from Solutions of V(IV) and sbhaH4: Positive Ion Mode
The major signal in the positive ion ESI-MS from a 1:2 V(IV):sbhaH4 solution at pH = 2 (m/zobs 300.4, 100%) was ascribed to the methanol adduct [VVO(sbhaH2)(CH3OH)]+ (m/zcalc 301.1, 6·CH3OH, Scheme 2) or its dimer [(VVO)2(sbhaH2)2(CH3OH)2]2+ (m/zcalc 301.1, 12·CH3OH, Scheme 2), which would be indistinguishable from the monomer by ESI-MS. This signal was present at 100% relative intensity from the solutions at pH = 2, 5, and 7 (Figure 4, panels a–c). Signals ascribed to the methanol free adduct [VVO(sbhaH2)]+ (m/zcalc 269.1, 6) or its dimer [(VVO)2(sbhaH2)2]2+ (m/zcalc 269.1, 12) were observed at lower abundance at all pH values (m/zobs 268.7, 3–7%).
Signals observed from the solution at pH = 5 (m/zobs 536.9, 6%) and 7 (m/zobs 536.9, 12%) were ascribed to [(VVO)2(sbhaH2)(sbhaH)]+ (m/zcalc 537.3, 15), which according to eq 4 could result from the single deprotonation of [(VVO)2(sbhaH2)2]2+ (12) or other pathways (Scheme 2). Signals observed from the solution at pH = 2 (m/zobs 568.7, 2%), 5 (m/zobs 568.8, 12%), and 7 (m/zobs 568.8, 20%) were ascribed to the methanol adduct of 15, [(VVO)2(sbhaH2)(sbhaH)(CH3OH)]+ (m/zcalc 569.3, 15·CH3OH). The relative intensities of the signals ascribed to 15 and 15·CH3OH would be expected to increase with increasing pH value, which was the case. The isotope patterns of the signal from the solution at pH = 5 and 7 centered at m/zobs 536.9 were not able to be simulated as a single V-sbhaH4 species (Figure 4, insets in panel b and c), suggesting that the signal comprised overlapping signals from 15 and one or more other V-sbhaH4 species.
The presence of the signal ascribed to 15 (m/zobs 536.9) supported the existence of dimeric V-sbhaH4 species. Mononuclear 6 could form dimeric 12, in which each sbhaH4 ligand bridges between two oxoV(V) centers (intermetal coordination) and dimeric 12a, in which each sbhaH4 ligand binds to discrete V(V) centers (intrametal coordination) which themselves are bound via a bis(μ-oxo) bridge. With six methylene groups separating the flanking hydroxamic acid groups, sbhaH4 sits at the boundary of the preference of dihydroxamic acids with methylene chain lengths n ≤ 6 to form dimeric complexes (eg, 12) and ligands with methylene chain lengths n ≥ 6 to form mononuclear complexes (eg, 6), as established by previous work.49,57−60
There was close to one m/z unit difference between a signal from the solutions at pH = 5 and 7 at m/zobs 536.9 and from the solution at pH = 2 at m/zobs 537.5. The difference was consistent with the presence of [(VVO)(VIVO)(sbhaH2)2]+ (m/zcalc 538.2, 14) at pH = 2 and the presence of its one-electron oxidized, single-deprotonated product 15 at pH = 5 and 7. Species 14 could arise from the dimerization of mononuclear 6 and 7 (eq 2) and/or from the one-electron oxidation of 13 (eq 6), itself a dimer of 7. Based upon the acid stability of V(IV), the concentration of 14 would be expected to be higher at low pH and to decrease at higher pH values. Support for the presence of mixed-valence V(V)/(IV)–sbhaH4 complexes at acid conditions is obtained from the crystallographically characterized mixed-valence V(V)2-V(IV)-quinic acid trimer, which was isolated from a water–ethanol solution of the V(V)-quinic acid dimer upon reducing the pH value from 7.0 to 3.3.(61) Several mixed-valence V(IV)/V(V) μ-oxo-bridged complexes have been characterized with O and N donor atoms.62−64 While the signal at m/zobs 537.5 from the spectra at pH = 2 simulated reasonably well as [(VVO)(VIVO)(sbhaH2)2]+ (14), an improved fit was obtained from assuming the presence of 80% [(VVO)(VIVO)(sbhaH2)2]+ (14) and 20% [(VVO)2(sbhaH2)(sbhaH)]+ (15) (Figure 4, panel a, inset). The signal at m/zobs 536.9 from the spectra at pH = 5 simulated as comprising 65% [(VVO)2(sbhaH2)(sbhaH)]+ (15) and 35% [(VVO)(VIVO)(sbhaH2)2]+ (14) and at pH = 7 as 80% [(VVO)2(sbhaH2)(sbhaH)]+ (15) and 20% [(VVO)(VIVO)(sbhaH2)2]+ (14) (Figure 4). In summary, the simplest model consistent with the positive ion ESI-MS data involved the presence of monomeric or dimeric [VVO(sbhaH2)]+ (6, 12) and the methanol adducts (6·CH3OH, 12·CH3OH), [(VVO)2(sbhaH2)(sbhaH)]+ (15) and the methanol adduct (15·CH3OH) and [(VVO)(VIVO)(sbhaH2)2]+ (14).
ESI-MS from Solutions of V(IV) and sbhaH4: Negative Ion Mode
The major signal in the negative ion ESI-MS from a 1:2 V(IV):sbhaH4 solution at pH = 2 (m/zobs 300.6, 90%) was ascribed to methanol adduct [VIVO(sbhaH)(CH3OH)]− (m/zcalc 300.1) or its dimer [(VIVO)2(sbhaH)2(CH3OH)2]2– (m/zcalc 300.1) (9·CH3OH and 19·CH3OH, respectively, Scheme 2). This signal was absent from the solution at pH = 5 and reappeared from the solution at pH = 7, which indicated that the signals were due to different species, even though the m/z values were similar. The signal (m/zobs 300.8, 20%) from the solution at pH = 7 was ascribed to the methanol adduct [VVO(sbha)(CH3OH)]− (m/zcalc 299.1) or its dimer [(VVO)2(sbha)2(CH3OH)2]2– (m/zcalc 299.1) (10·CH3OH and 24·CH3OH, respectively, Scheme 2). The one-electron oxidation of [VIVO(sbhaH)(CH3OH)]− (9·CH3OH) would produce the MS-inactive [VVO(sbhaH)(CH3OH)]0 (8·CH3OH) consistent with the absence of a signal from the solution at pH = 5, and the deprotonation of [VVO(sbhaH)(CH3OH)]0 (8·CH3OH) would form the MS-active [VVO(sbha)(CH3OH)]− (10·CH3OH) at pH = 7. Signals ascribed to dimeric [(VVO)2(sbhaH)(sbha)]− (m/zcalc 535.3, 21) were observed from the solution at pH = 5 (m/zobs 534.9, 6%) and 7 (m/zobs 534.9, 42%). The isotope pattern of the signal simulated well as 21 present as a single species (Figure 4, insets in panel e and f). The relative concentration of 10, 24, and 21 would be expected to increase with increasing pH value, which was the case. The signals observed from the solution at pH = 2 (m/zobs 568.7, 42% and m/zobs 569.8, 47%) were ascribed to the methanol adduct of the mixed-valence dimer [(VVO)(VIVO)(sbhaH)2(CH3OH)]− (m/zcalc 568.3, 20·CH3OH) and the methanol adduct [(VIVO)2(sbhaH2)(sbhaH)(CH3OH)]− (m/zcalc 569.3, 16·CH3OH), respectively. The isotope pattern in this region of the spectrum from the solution at pH = 2 indicates that 16·CH3OH and 20·CH3OH were present at about equal relative concentration.
ESI-MS from Solutions of V(IV) and sbhaH4: Closing Comments
At any given pH value, solutions of V(IV) and shhaH4 analyzed by ESI-MS showed signals that could be ascribed to monomeric or dimeric V(V)/(IV)-sbhaH4 species that differed in the level of deprotonation, the oxidation state of the V center(s), and in the overall charge of the complex. In total, the presence of 11 MS-active V(V)/(IV)-sbhaH4 species have been proposed (marked by circles around the species number in Scheme 2; note 6 is shown twice in eqs 1 and 2). Since three of these 11 species (12, 19, and 24) are dimers that cannot be distinguished from the respective monomers (6, 9, and 10), the minimal speciation model from ESI-MS data supported the presence of 8 species. At all pH values, the dominant species from solutions of V(IV) and sbhaH4 detected in the positive ion ESI-MS was 6·CH3OH and/or its dimer 12·CH3OH (Figure 5). At pH = 2, a higher relative concentration of V(IV)-sbhaH4 species (9·CH3OH, 19·CH3OH, 16·CH3OH) and V(IV)/(V) species (14, 20·CH3OH) was present, with these species not evident in significant concentrations at pH = 5 and above. The V(V)-sbhaH4 species 15, 15·CH3OH, 10, 10·CH3OH, 24, 24·CH3OH, 21, and 21·CH3OH were not evident at pH = 2 but were detectable at low levels at pH = 5 and increased in relative concentration at pH = 7 (Figure 5). The V(V)/(IV)-sbhaH4 speciation profile was internally consistent across the positive and negative ion ESI-MS data. For example, the four-step deprotonation of dimeric [(VVO)2(sbhaH2)2]2+ (m/zcalc 269.1; m/zobs 268.7, 12) to [(VVO)2(sbhaH2)(sbhaH)]+ (m/zcalc 537.3; m/zobs 536.9, 15) to [(VVO)2(sbhaH)2]0 (MS-inactive, 18) to [(VVO)2(sbhaH)(sbha)]− (m/zcalc 535.3; m/zobs 534.9, 21) to [(VVO)2(sbha)2]2– (m/zcalc 267.1; m/zobs 266.9, 24) was consistent with the positive and negative ion ESI-MS data.
Figure 5.
Distribution of species from 1:2 solutions of V(IV) and sbhaH4 at pH = 2, 5, and 7, as measured by ESI-MS. V(V)-, V(IV)-, or mixed-valence V(V)/(IV)-sbhaH4 species are represented by closed (black), open, or closed (gray) symbols, respectively, and by the species number, according to Scheme 2. The relative concentrations are presented as the sum of the relative intensity of the signals of a species (eg, 6) and its methanol adduct (eg, 6.M), according to Table 1.
At higher pH values, the dominant species present in a solution prepared from V(IV) and sbhaH4 tended toward the bottom right-hand region of Scheme 2. This was consistent with the increased concentrations at higher pH values of the V(V) ion and the hydroximate form of sbhaH4. The V(V)/(IV)-sbhaH4 speciation profile can be broadly represented as a vector sum (Scheme 2, inset, dotted vector) of a pH-dependent vector that describes the oxidation of V(IV) to V(V) (low to high pH, respectively) (Scheme 2, inset, shorter solid vector) and a pH-dependent vector that describes the deprotonation of hydroxamate to hydroximate (low to high pH, respectively) (Scheme 2, inset, longer solid vector).
51V NMR Spectroscopy
A solution prepared from V(IV) and pbH2 containing [VVO(pb)]+ should be detectable by 51V NMR spectroscopy (V(V), d0). The 51V NMR spectrum from an approximately V(IV):pbH2 = 1:1 solution at pH = 2 showed a signal at −443.3 ppm (Figure 6a), which was within the range for selected five- and six-coordinate V(V)–hydroxamato complexes at low pH values and also other V(V) complexes with O,O′ coordination, such as diols and α-hydroxycarboxylic acids.65−69 There were no signals attributable to polyoxovanadate species ([HVO4]3–, −557 ppm; [V2O7]4–, −571 ppm; [V4O12]4–,–577 ppm) in the spectrum(70) which suggested that the signal was attributable to [VVO(pb)]+ or [VVO(OH)(pb)].
Figure 6.
51V NMR spectra referenced to VOCl3 (0 ppm) from a: (a) 1:1 solution of V(IV):pbH2 in CD3OD; 1:2 solution of V(IV):sbhaH4 in D2O at (b) pH = 2, (c) pH = 5, or (d) pH = 7 or a (e) 1:3 solution of V(IV):sbhaH4 in D2O at pH = 7. Polyoxovanadate species are denoted by *.
A signal in the 51V NMR spectrum at −432.2 ppm from a 1:2 solution of V(IV):sbhaH4 at pH = 2 suggested the presence of a single V(V)-sbhaH4 species (Figure 6b). This is consistent with the posit that there exists a mixture of V(IV)-sbhaH4 and V(V)-sbhaH4 species in a solution prepared from V(IV) and sbhaH4 at pH = 2. Similar to the case with pbH2, there were no signals due to polyoxovanadate species at this pH value. The signal at −432 ppm was absent from V(IV):sbhaH4 = 1:2 solutions at pH = 5 (Figure 6c) and 7 (Figure 6d) with broad signals ascribed to V(V)–sbhaH4 complexes appearing at −478 or −493 ppm, at the respective pH values. The relative intensity of the signal at −493 ppm increased at V(IV):sbhaH4 = 1:3, pH = 7 (Figure 6e). The significant upfield shift of these signals from −432.2 ppm at pH = 2 indicated the formation of different V(V)-sbhaH4 species, possibly arising from a mixture of hydroxamate- and hydroximate-coordination modes. At pH = 5 and 7, signals due to polyoxovanadate species ([V10O28]6–, [H2V10O28]4–, [HVO4]2–, [V2O7]4–, [V4O12]4–) were evident (signals marked with * in Figure 6).
EPR Spectroscopy
If [VVO(pb)]+ was the dominant species formed from solutions of V(IV) and pbH2, then these solutions would be expected to be EPR silent. Compared to the EPR signal (150 K) from a methanol glassy solution of VOSO4 (10 mM, Figure 7a), there was no signal in the EPR spectrum from a methanol glassy solution of V(IV) and pbH2 at pH = 2 (Figure 7b), which supports the notion that these solutions contained [VVO(pb)]+. The calculated EPR parameters from the VOSO4 spectrum as simulated using QPOW(71) (g∥ = 1.933, A∥ = 181.2 × 10–4 cm–1; g⊥ = 1.976, A⊥ = 70.7 × 10–4 cm–1) agreed well with literature values for VOSO4 (g∥ = 1.933, A∥ = 183 × 10–4 cm–1; g⊥ = 1.978, A⊥ = 71 × 10–4 cm–1).72,73 A methanol glassy solution of V(IV) and sbhaH4 at approximately pH = 2 gave an EPR signal (Figure 7c) that indicated the presence of more than one species, which was more clearly evident from the signal at the −5/2 resonance (inset). It was reasonable to assume that this solution contained a mixture of VOSO4 and V(IV)-sbhaH4 species. Therefore, while solutions of V(IV) and pbH2 exclusively yielded V(V)-pbH2 species, solutions of V(IV) and sbhaH4 yielded a mixture of V(IV)-sbhaH4 species, as evidenced from the EPR spectroscopic data, and V(V)-sbhaH4 species, as evidenced from the 51V NMR spectroscopic and electronic absorption spectroscopic data. This was also consistent with the distribution of V(V)- and V(IV)-sbhaH4 species detected by ESI-MS (Table 1, Figure 5). A second spectrum was acquired from a different solution prepared from VOSO4 and sbhaH4 with the pH value approximately at pH = 2 (Figure 7d) which indicated the presence of VOSO4 and V(IV)-sbhaH4 species in different relative concentrations to Figure 7c (refer to −5/2 resonance in inset). The solution from Figure 7d contained a higher relative concentration of V(IV)-sbhaH4 species and enabled the calculation of the EPR parameters of the V(IV)-sbhaH4 species as: g∥ = 1.939, A∥ = 170.1 × 10–4 cm–1; g⊥ = 1.979, A⊥ = 63.4 × 10–4 cm–1. The values of the line widths at half height for the V(IV)-sbhaH4 species (W⊥ = 8.0 × 10–4 cm–1; W∥ = 6.0 × 10–4 cm–1) were almost twice the values for VOSO4 (W⊥ = 5.0 × 10–4 cm–1; W∥ = 4.0 × 10–4 cm–1), which suggested that more than one V(IV)-sbhaH4 species was present. The most likely species to be attributed to the V(IV)-sbhaH4 EPR signal were 9·CH3OH, 19·CH3OH, or 16·CH3OH, since these were present in relatively high concentration according to the ESI-MS data. The relative concentrations of VOSO4 and V(IV)-sbhaH4 species in the solution from Figure 7c were 70:30 and in the solution from Figure 7d were 10:90. The increased signal-to-noise of the spectra in Figure 7d compared to Figure 7c indicated that the total concentration of V(IV) species in the solution from Figure 7d was less than that in Figure 7c. An EPR spectrum from a solution of VOSO4 and sbhaH4 at pH = 5 was EPR silent (Figure 7e). Therefore, the pH value of the solution in Figure 7d was likely to have been above pH = 2. The higher relative concentration of EPR silent V(V)-sbhaH4 species at pH values >5 was consistent with the V(V)/(IV)-sbhaH4 speciation model from the ESI-MS data.
Figure 7.
EPR spectra (150 K) from a methanol glass of: (a) VOSO4·5H2O, (b) V(IV):pbH2 = 1:1 (pH = 2), (c) V(IV):sbhaH4 = 1:2 (pH = 2), (d) V(IV):sbhaH4 = 1:2 (2 < pH < 5), and (e) V(IV):sbhaH4 = 1:2 (pH = 5). Traces in black or gray are experimental or simulated spectra, respectively.
Cyclic Voltammetry
As supported by data from ESI-MS and 51V NMR spectroscopy, the major species present in a solution of V(IV) and pbH2 were due to [VVO(pb)]+ or its dimer. The absence of a signal in the EPR spectrum from these solutions suggested that the concentration of V(IV) species was negligible. Analogous studies with the linear dihydroxamic acid sbhaH4 showed a distribution of monomeric and dimeric V(IV) and V(V) species and mixed-valence V(V)/(IV) species. These results indicated that the thermodynamic stability of a complex formed between V(V) and the macrocyclic dihydroxamic acid pbH2 would be greater than that with the linear dihydroxamic acid, which suggested that the V(V)/(IV) redox potential of [VVO(pb)]+ would be less than that of the V-sbhaH4 system. Cyclic voltammetry from a 1:1 solution of V(IV):pbH2 at pH = 2 (Figure 8) showed a reversible reduction with a half-wave potential E1/2 = −335 mV (Figure 8, solid line). The half-wave potential of the cyclic voltammogram from a 1:2 solution of V(IV):sbhaH4 at pH = 2 was E1/2 = −352 mV (Figure 8, dashed line). This was the opposite of what was predicted based on the solution speciation results (E1/2 [VO(pb)]+/0 < VV/IV-sbhaH4). The difference of 17 mV in the half-wave potential is rather small. Second, while a 1:1 solution of V(IV):pbH2 at pH = 2 yielded [VVO(pb)]+, the 1:2 solution of V(IV):sbhaH4 at pH = 2 contained at a minimum VOSO4 and a mixture of V(V)-sbhaH4, V(IV)-sbhaH4, and V(V)/(IV)-sbhaH4 species (Table 1), which would prevent the determination of the half-wave potential of a unique species.
Figure 8.
Cyclic voltammograms from solutions of [V(IV)]:[pbH2] = 1:1 (solid line) or [V(IV)]:[sbhaH4] = 1:2 (dashed line) in 0.1 M NaCl at pH = 2.
Concluding Remarks
Multiple spectroscopic methods have shown that the monooxoV(V) complex [VVO(pb)]+ was the dominant species formed from solutions of V(IV) and the cyclic dihydroxamic acid pbH2. As predicted, the cyclic dihydroxamic acid is suitably preorganized for oxoV(V) coordination. The characterization of [VVO(pb)]+ expands the small family of V–siderophore complexes that have been described. Solutions of V(IV) and the linear dihydroxamic acid sbhaH4 gave mixtures with higher relative concentrations of hydroxamate-based V(IV)-sbhaH4, V(IV)/V(V)-sbhaH4, and V(V)-sbhaH4 species at pH = 2 and higher concentrations of hydroximate-based V(V)-sbhaH4 species at pH = 7. The complexity of the V-sbhaH4 solution equilibria arose from phenomena including dimerization (2[VVO(sbhaH2)]+ ↔ [(VVO)2(sbhaH2)2]2+), deprotonation ([VVO(sbhaH2)]+ – H+ ↔ [VVO(sbhaH)]0), and oxidation ([VIVO(sbhaH2)]0 −e– ↔ [VVO(sbhaH2)]+) and can be described as the sum of two pH-dependent vectors, the first comprising the deprotonation of hydroxamate to hydroximate (low to high pH, respectively) and the second comprising the oxidation of V(IV) to V(V) (low to high pH, respectively).
The restricted conformational freedom of pbH2 compared to linear sbhaH4 likely accounts for the entropic-based increase in the thermodynamic stability of [VVO(pb)]+ compared to that of the V-sbhaH4 species. The preorganization of metal binding functional groups in macrocyclic peptides manifests as greater selectivity and stronger binding compared to their linear analogues74,75 and is reflected in the greater stability of Fe(III) complexes of cyclic hydroxamic acid-based siderophores, such as alcaligin (1/2log β230 = 32.4) and desferrioxamine E (log β110 = 32.5), compared to linear siderophores, such as desferrioxamine B (log β110 = 30.5).76,77 The stability of [VVO(pb)]+ suggested to us that the oxoV(V) ion could be used to preorganize the assembly of two endohydroxamic acid amino carboxylic acid units prior to end-to-end peptide-based cyclization to furnish [VVO(pb)]+. We will shortly publish our results of the V(V)-based templated synthesis of [VVO(pb)]+ and new cyclic dihydroxamic acids.
Each of pbH2 and the related bisucaberin are siderophores native to marine bacteria, including species of the genus Shewanella. The formation of [VVO(pb)]+ at pH values 2–7 is relevant in the context of the competition between pbH2 and Fe(III) or V(V) in surface oxic marine waters and provides knowledge of the ligands potentially involved in V acquisition and uptake, so-called ‘vanadophores’, in microorganisms and other forms of life.(20)
Acknowledgments
Funding from the University of Sydney (Bridging Grant 2009 to R.C. and University Postgraduate Awards cofunded to A.A.H.P. and C.Z.S.) is gratefully acknowledged. We acknowledge the Australian Research Council and the Wellcome Trust Equipment Fund for supporting the Elexsys 500 EPR spectrometer. Dr. Aviva Levina and Dr. Keith Fisher are kindly acknowledged for acquiring the electrochemistry and EPR data, respectively.
Supporting Information Available
Positive and negative ion mode ESI-MS data from 1:2 solutions of V(IV):sbhaH4 at pH = 2, 5, 7, and 9 and from 1:1 solutions of V(IV):sbhaH4 at pH = 2 (positive ion mode). This material is available free of charge via the Internet at http://pubs.acs.org.
Supplementary Material
References
- Budzikiewicz H. In Progress in the Chemistry of Organic Natural Products; Kinghorn A. D., Falk H., Kobayashi J., Eds.; Springer-Verlag: New York, 2010; Vol. 92, p 1–75. [Google Scholar]
- Hider R. C.; Kong X. Nat. Prod. Rep. 2010, 27, 637–657. [DOI] [PubMed] [Google Scholar]
- Miller M. J.; Zhu H.; Xu Y.; Wu C.; Walz A. J.; Vergne A.; Roosenberg J. M.; Moraski G.; Minnick A. A.; McKee-Dolence J.; Hu J.; Fennell K.; Dolence E. K.; Dong L.; Franzblau S.; Malouin F.; Mollmann U. BioMetals 2009, 22, 61–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Butler A.; Theisen R. M. Coord. Chem. Rev. 2010, 254, 288–296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandy M.; Butler A. Chem. Rev. 2009, 109, 4580–4595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Butler A. BioMetals 2005, 18, 369–374. [DOI] [PubMed] [Google Scholar]
- Crumbliss A. L.; Harrington J. M. Adv. Inorg. Chem. 2009, 61, 179–250. [Google Scholar]
- Braun V.; Hantke K. In Microbial Transport Systems; Winkelmann G., Ed.; Wiley-VCH: Weinheim, Germany, 2002, p 289–311. [Google Scholar]
- Miethke M.; Marahiel M. A. Microbiol. Mol. Biol. Rev. 2007, 71, 413–451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winkelmann G. Biochem. Soc. Trans. 2002, 30, 691–696. [DOI] [PubMed] [Google Scholar]
- Raymond K. N.; Dertz E. A. In Iron Transport in Bacteria; Crosa J. H., Mey A. R., Payne S. M., Eds.; ASM Press: Washington, DC, 2004, p 3–17. [Google Scholar]
- Boukhalfa H.; Crumbliss A. L. BioMetals 2002, 15, 325–339. [DOI] [PubMed] [Google Scholar]
- Drechsel H.; Winkelmann G. In Transition Metals in Microbial Metabolism; Winkelmann G., Carrano C. J., Eds.; Harwood Academic: Amsterdam, The Netherlands, 1997, p 1–49. [Google Scholar]
- Marmion C. J.; Griffith D.; Nolan K. B. Eur. J. Inorg. Chem. 2004, 3003–3016. [Google Scholar]
- Liu J.; Obando D.; Schipanski L. G.; Groebler L. K.; Witting P. K.; Kalinowski D. S.; Richardson D. R.; Codd R. J. Med. Chem. 2010, 53, 1370–1382. [DOI] [PubMed] [Google Scholar]
- Codd R.; Braich N.; Liu J.; Soe C. Z.; Pakchung A. A. H. Int. J. Biochem. Cell Biol. 2009, 41, 736–739. [DOI] [PubMed] [Google Scholar]
- Braich N.; Codd R. Analyst 2008, 133, 877–880. [DOI] [PubMed] [Google Scholar]
- Minucci S.; Pelicci P. G. Nat. Rev. Cancer 2006, 6, 38–51. [DOI] [PubMed] [Google Scholar]
- Codd R. Coord. Chem. Rev. 2008, 252, 1387–1408. [Google Scholar]
- Rehder D. Org. Biomol. Chem. 2008, 6, 957–964. [DOI] [PubMed] [Google Scholar]
- Bellenger J. P.; Wichard T.; Kraepiel A. M. L. Appl. Environ. Microbiol. 2008, 74, 1478–1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Butler A.; Parsons S. M.; Yamagata S. K.; de la Rosa R. I. Inorg. Chim. Acta 1989, 163, 1–3. [Google Scholar]
- Bell J. H.; Pratt R. F. Biochemistry 2002, 41, 4329–4338. [DOI] [PubMed] [Google Scholar]
- Goldwaser I.; Li J.; Gershonov E.; Armoni M.; Karnieli E.; Fridkin M.; Shechter Y. J. Biol. Chem. 1999, 274, 26617–26624. [DOI] [PubMed] [Google Scholar]
- Haratake M.; Fukunaga M.; Ono M.; Nakayama M. J. Biol. Inorg. Chem. 2005, 10, 250–258. [DOI] [PubMed] [Google Scholar]
- Karpishin T. B.; Raymond K. N. Angew. Chem., Int. Ed. Engl. 1992, 31, 466–468. [Google Scholar]
- Karpishin T. B.; Dewey T. M.; Raymond K. N. J. Am. Chem. Soc. 1993, 115, 1842–1851. [Google Scholar]
- Luterotti S.; Grdinic V. Analyst 1986, 111, 1163–1165. [Google Scholar]
- Ledyard K. M.; Butler A. J. Biol. Inorg. Chem. 1997, 2, 93–97. [Google Scholar]
- Kadi N.; Arbache S.; Song L.; Oves-Costales D.; Challis G. L. J. Am. Chem. Soc. 2008, 130, 10458–10459. [DOI] [PubMed] [Google Scholar]
- Gram L. Appl. Environ. Microbiol. 1994, 60, 2132–2136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brickman T. J.; Anderson M. T.; Armstrong S. K. BioMetals 2007, 20, 303–322. [DOI] [PubMed] [Google Scholar]
- Nishio T.; Tanaka N.; Hiratake J.; Katsube Y.; Ishida Y.; Oda J. J. Am. Chem. Soc. 1988, 110, 8733–8734. [Google Scholar]
- Kameyama T.; Takahashi A.; Kurasawa S.; Ishizuka M.; Okami Y.; Takeuchi T.; Umezawa H. J. Antibiot. 1987, 40, 1664–1670. [DOI] [PubMed] [Google Scholar]
- Kadi N.; Song L.; Challis G. L. Chem. Commun. 2008, 5119–5121. [DOI] [PubMed] [Google Scholar]
- Hou Z.; Sunderland C. J.; Nishio T.; Raymond K. N. J. Am. Chem. Soc. 1996, 118, 5148–5149. [Google Scholar]
- Carrano C. J.; Raymond K. N. J. Am. Chem. Soc. 1978, 100, 5371–5374. [Google Scholar]
- Boukhalfa H.; Brickman T. J.; Armstrong S. K.; Crumbliss A. L. Inorg. Chem. 2000, 39, 5591–5602. [DOI] [PubMed] [Google Scholar]
- Bergeron R. J.; McManis J. S. Tetrahedron 1989, 45, 4939–4944. [Google Scholar]
- Bergeron R. J.; McManis J. S.; Perumal P. T.; Algee S. E. J. Org. Chem. 1991, 56, 5560–5563. [Google Scholar]
- Fisher D. C.; Barclay-Peet S. J.; Balfe C. A.; Raymond K. N. Inorg. Chem. 1989, 28, 4399–4406. [Google Scholar]
- Gez S.; Luxenhofer R.; Levina A.; Codd R.; Lay P. A. Inorg. Chem. 2005, 44, 2934–2943. [DOI] [PubMed] [Google Scholar]
- Pakchung A. A. H.; Soe C. Z.; Codd R. Chem. Biodivers. 2008, 5, 2113–2123. [DOI] [PubMed] [Google Scholar]
- Simpson P. J. L.; Richardson D. J.; Codd R. Microbiology 2010, 156, 302–312. [DOI] [PubMed] [Google Scholar]
- Butler A. Science 1998, 281, 207–210. [DOI] [PubMed] [Google Scholar]
- Abbasi S. Anal. Chem. 1976, 48, 714–717. [Google Scholar]
- Pande K. R.; Tandon S. G. J. Inorg. Nucl. Chem. 1980, 42, 1509. [Google Scholar]
- Monga V.; Thompson K. H.; Yuen V. G.; Sharma V.; Patrick B. O.; McNeill J. H.; Orvig C. Inorg. Chem. 2005, 44, 2678–2688. [DOI] [PubMed] [Google Scholar]
- Spasojevic I.; Boukhalfa H.; Stevens R. D.; Crumbliss A. L. Inorg. Chem. 2001, 40, 49–58. [DOI] [PubMed] [Google Scholar]
- Pecoraro V. L. Inorg. Chim. Acta 1989, 155, 171–173. [Google Scholar]
- Brown D. A.; Glass W. K.; Mageswaran R.; Girmay B. Magn. Reson. Chem. 1988, 26, 970–973. [Google Scholar]
- Brown D. A.; Glass W. K.; Mageswaran R.; Mohanmmed S. A. Magn. Reson. Chem. 1991, 29, 40–45. [Google Scholar]
- Brown D. A.; Coogan R. A.; Fitzpatrick N. J.; Glass W. K.; Abukshima D. E.; Shiels L.; Ahlgrén M.; Smolander K.; Pakkanen T. T.; A. P. T.; Peräkylä M. J. Chem. Soc., Perkins Trans. 2 1996, 2673–2679. [Google Scholar]
- Schraml J.; Kvícalová M.; Blechta V.; Soukupová L.; Exner O.; Boldhaus H.-M.; Erdt F.; Bliefert C. Magn. Reson. Chem. 2000, 38, 795–801. [Google Scholar]
- Kakkar R.; Grover R.; Chadha P. Org. Biomol. Chem. 2003, 1, 2200–2206. [DOI] [PubMed] [Google Scholar]
- Comiskey J.; Farkas E.; Krot-Lacina K. A.; Pritchard R. R.; McAuliffe C. A.; Nolan K. B. Dalton Trans. 2003, 4243–4249. [Google Scholar]
- Evers A.; Hancock R. D.; Martell A. E.; Motekaitis R. J. Inorg. Chem. 1989, 28, 2189–2195. [Google Scholar]
- Caudle M. T.; Cogswell L. P. I.; Crumbliss A. L. Inorg. Chem. 1994, 33, 4759–4773. [Google Scholar]
- Farkas E.; Bátka D.; Pataki Z.; Buglyó P.; Santos M. A. Dalton Trans. 2004, 1248–1253. [DOI] [PubMed] [Google Scholar]
- Brown D. A.; Geraty R.; Glennon J. D.; Choileain N. N. Inorg. Chem. 1986, 25, 3792–3796. [Google Scholar]
- Codd R.; Hambley T. W.; Lay P. A. Inorg. Chem. 1995, 34, 877–882. [DOI] [PubMed] [Google Scholar]
- Huang X.-H.; Huang C.-C.; Qin X.-H.; Zhai L.-S.; Liu D.-S. Inorg. Chem. Commun. 2008, 11, 1236–1238. [Google Scholar]
- Chen C.-Y.; Zhou Z.-H.; Chen H.-B.; Huang P.-Q.; Tsai K.-R.; Chow Y. L. Inorg. Chem. 2008, 47, 8714–8720. [DOI] [PubMed] [Google Scholar]
- Jin Y.; Lee H.-I.; Pyo M.; Lah M. S. Dalton Trans. 2005, 797–803. [DOI] [PubMed] [Google Scholar]
- Rehder D.; Weidemann C.; Duch A.; Priebsch W. Inorg. Chem. 1988, 27, 584–587. [Google Scholar]
- Crans D. C.; Felty R. A.; Chen H.; Eckert H.; Das N. Inorg. Chem. 1994, 33, 2427–2438. [Google Scholar]
- Hati S.; Batchelor R. J.; Einstein F. W. B.; Tracey A. S. Inorg. Chem. 2001, 40, 6258–6265. [DOI] [PubMed] [Google Scholar]
- Yamaki R. T.; Paniago E. B.; Carvalho S.; Lula I. S. J. Chem. Soc., Dalton Trans. 1999, 4407–4412. [Google Scholar]
- Jiang F.; Anderson O. P.; Miller S. M.; Chen J.; Mahroof-Tahir M.; Crans D. C. Inorg. Chem. 1998, 37, 5439–5451. [DOI] [PubMed] [Google Scholar]
- Rehder D. In.Transition Metal Nuclear Magnetic Resonance; Pregosin P. S., Ed.; Elsevier: Amsterdam, The Netherlands, 1991, p 1–58. [Google Scholar]
- Nilges M. J. PhD Thesis, University of Illinois: Champaign, IL, 1979. [Google Scholar]
- Albanese N. F.; Chasteen N. D. J. Phys. Chem. 1978, 82, 910–914. [Google Scholar]
- Chasteen N. D. In Biological Magnetic Resonance; Berliner L. J. R., J., Ed.; Plenum Press: New York, 1981; Vol. 3, p 53–119. [Google Scholar]
- McGeary R. P.; Fairlie D. P. Curr. Opin. Drug Discovery Dev. 1998, 1, 208–217. [PubMed] [Google Scholar]
- Driggers E. M.; Hale S. P.; Lee J.; Terrett N. K. Nat. Rev. Drug Discovery 2008, 7, 608–624. [DOI] [PubMed] [Google Scholar]
- Hou Z.; Raymond K. N.; O’Sullivan B.; Esker T. W.; Nishio T. Inorg. Chem. 1998, 37, 6630–6637. [DOI] [PubMed] [Google Scholar]
- Spasojevic I.; Armstrong S. K.; Brickman T. J.; Crumbliss A. L. Inorg. Chem. 1999, 38, 449–454. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.










